PROM1 and cancer: In addition, the downregulation of stem cell surface markers (AFP, EpCAM, CD133, CD24, and ALDH1A), Wnt and Notch pathway genes, and drug resistance genes was observed, indicating that the EpCAM-apt-Dox targets and impairs cancer stem like cell properties.